Cellectis to Report Third Quarter 2022 Financial Results
Published on October 27, 2022 in New York, NY
October 27, 2022 - New York, NY –– Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the third quarter ended September 30th, 2022, on Thursday, November 3rd, 2022, after the close of the US market.
The announcement will be followed by a conference call and live audio webcast on Friday, November 4th, 2022, at 8:00 AM EDT / 2:00 PM CET. The call will include the Company’s third quarter results and an update on business activities. Details for the call are as follows:
Friday, November 4th at 8:00 a.m. Eastern Time:
Domestic: 1-877-413-2411
International:1-201-389-0882
Conference ID:13732988
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1571941&tp_key=ebcf814947